Reconstructing early HIV

Reconstructing early HIV The search for immunogens delves into the virus' past By Kelly Rae Chi Related Articles 5 HIV Treatment Strategies A piggyback attack: Using the common cold to deliver an HIV vaccine The best offense? CCR5 inhibitors, with one now on the market, suggest it may be a good defense Stem cells and gene therapy: Researchers take a second look at using stem cells to treat HIV Solving the viral spike: Can structural bio

Kelly Rae Chi

| 3 min read

Listen with Speechify

0:00

3:00

By Kelly Rae Chi

5 HIV Treatment Strategies

A piggyback attack: Using the common cold to deliver an HIV vaccine

The best offense? CCR5 inhibitors, with one now on the market, suggest it may be a good defense

Stem cells and gene therapy: Researchers take a second look at using stem cells to treat HIV

Solving the viral spike: Can structural biology find a chink in HIV's armor?

Profile: A Receptive Leader: Panacos' Graham Allaway

PODCAST: Andrea Gawrylewski interviews NIAID director Anthony Fauci, who gives his take on HIV research priorities.

How do you choose a candidate immunogen for an HIV vaccine? For some researchers, the search starts by looking at the most ancient strains of the virus. In the late 1990s, "one of our questions was: was the failure of the previous generation of vaccines due to the fact that the immunogens were too dissimilar to actual circulating viruses," ...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!

Join for free today

Already a member? Login Here